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Abstract
Rationale The neurotransmitter serotonin (5-HT) has been
implicated in both aversive processing and impulsivity.
Reconciling these accounts, recent studies have demon-
strated that 5-HT is important for punishment-induced
behavioural inhibition. These studies focused on situations
where actions lead directly to punishments. However,
decision-making often involves making tradeoffs between
small ‘local’ costs and larger ‘global’ losses.
Objective We aimed to distinguish whether 5-HT promotes
avoidance of local losses, global losses, or both, in contrast
to an overall effect on reflection impulsivity. We further
examined the influence of individual differences in sub-
clinical depression, anxiety and impulsivity on global and
local loss avoidance.
Methods Healthy volunteers (N=21) underwent an acute
tryptophan depletion procedure in a double-blind, placebo-
controlled crossover design. We measured global and local
loss avoidance in a decision-making task where subjects
could sample information at a small cost to avoid making
incorrect decisions, which resulted in large losses.
Results Tryptophan depletion removed the suppressive
effects of small local costs on information sampling
behaviour. Sub-clinical depressive symptoms produced
effects on information sampling similar to (but independent
from) those of tryptophan depletion. Dispositional anxiety
was related to global loss avoidance. However, trait
impulsivity was unrelated to information sampling.
Conclusions The current findings are consistent with recent
theoretical work that characterises 5-HT as pruning a tree of
potential decisions, eliminating options expected to lead to
aversive outcomes. Our results extend this account by
proposing that 5-HT promotes reflexive avoidance of
relatively immediate aversive outcomes, potentially at the
expense of more globally construed future losses.
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Growing evidence points to a selective role for the neurotrans-
mitter serotonin (5-HT) in aversive processing (Soubrie, 1986;
Deakin and Graeff, 1991; Tye et al., 1977; Boureau and
Dayan 2011; Cools et al. 2011). Abnormal 5-HT function has
been linked to psychopathologies associated with negative
affect such as depression and anxiety (Neumeister, 2003;
Harmer, 2008; Owens and Nemeroff, 1994; Graeff, 2002;
Wise et al., 1972). Research in healthy animals and humans
suggests that 5-HT is important for inhibiting behaviours that
lead to punishment (Tye et al., 1977; Crockett et al., 2009;
Geller et al., 1960; Stevens et al., 1969; Graeff and
Schoenfeld, 1970; Wise et al., 1973; Thiébot et al., 1982;
Cervo et al., 2000; Graeff, 2002). More recent work has
refined this hypothesis by developing more sophisticated
notions of how appetitive and aversive processes interact with
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activational and inhibitory processes (Boureau and Dayan
2011; Cools et al. 2011; Crockett et al., 2009). This work
proposes that 5-HT plays a crucial role at the intersection of
punishment and inhibition, translating aversive predictions
into adaptive behavioural inhibition in a context-sensitive
manner.
So far, studies in this area have focused on processing
related to aversive outcomes resulting immediately from single
actions (e.g., lever or button presses). However, many actions
take place in the context of larger sequences, and in such
contexts, an actor sometimes must choose whether to incur a
small immediate loss in order to avoid a larger future loss. This
tradeoff is central to many everyday decisions such as whether
to purchase insurance, take exercise, or undergo mildly painful
preventative medical procedures. In these kinds of decisions,
aversive predictions occur at both the local level (expected pain
of a dental cleaning) and the global level (expected pain of a
root canal). There is evidence from the mental accounting
literature that people segregate (rather than integrate) their
evaluations of compound outcomes; in other words, a loss of
$100 plus a loss of $25 is not psychologically equivalent to a
loss of $125 (Thaler, 1985). Moreover, research on construal
level theory (Trope and Liberman, 2003) has shown that
people represent psychologically distant events in an abstract,
global fashion, whereas they represent psychologically
proximal events in a concrete, local fashion. Construal level
influences a range of processes important for decision-
making (Dhar and Kim, 2007) such as probability estimation
(Wakslak and Trope, 2009) and temporal discounting (Trope
and Liberman, 2000). This indicates that people distinguish
between global and local losses and that this distinction
influences their decision-making. In the current study,
we investigated to what extent 5-HT influences aversive
processes at the local versus global level.
5-HT has also been implicated in impulsivity. However,
attempts to specify the precise relationship between 5-HT
function and impulsivity have been only partly successful;
5-HT appears to play a role in some forms of impulsivity
but not others (Robbins and Crockett, 2010; Evenden,
1999; Winstanley et al., 2004; Clark et al., 2005).
‘Reflection impulsivity’ is the tendency to make decisions
before gathering sufficient or appropriate information
(Kagan, 1966). This facet of pre-decisional impulsivity
has received minimal research attention to date, and it is
currently unclear whether tests of reflection impulsivity
load primarily on the cognitive/risk-taking dimension or on
the response inhibition dimension identified by impulsivity
factor analyses (Reynolds et al., 2006; Meda et al., 2009).
In rats, the effects of 5-HT manipulations on reflection
impulsivity are mixed. Evenden (1999) reported a pro-
impulsive effect of the 5-HT2 antagonist ritanserin, an anti-
impulsive effect of the 5-HT2 agonist DOI, both pro- and
anti-impulsive effects of the 5-HT1A agonist 8-OH-DPAT,
and no effects of the SSRI citalopram or the 5-HT1A
antagonist WAY-100635. No study has yet examined the
effects of manipulating 5-HT on reflection impulsivity in
humans.
We examined the effects of acute tryptophan depletion
(ATD), a dietary procedure that temporarily lowers brain 5-
HT levels (Biggio et al., 1974; Gessa et al., 1974; Moja et
al., 1989; Ardis et al., 2009; Stancampiano et al., 1997;
Carpenter et al., 1998), on behaviour in an Information
Sampling Task (Clark et al., 2006) that allowed us to study
global and local loss avoidance as well as reflection
impulsivity. On each trial, subjects were instructed to
accumulate as much information as they wished before
making a decision. Information sampling predicted the
probability of making a correct decision. Correct decisions
won points that were exchangeable for money, and
incorrect decisions lost points. We tested the effects of
ATD on information sampling behaviour in two conditions.
In the “Free” condition, there was no cost to sampling
information. In terms of losses, subjects in this condition
should only be concerned with losing money for incorrect
decisions. Normatively, subjects should sample as much
information as possible in order to avoid losing money at
the end of the trial. In the “Costly” condition, subjects'
potential winnings (if correct) decreased in direct propor-
tion with the amount of information sampled. Thus, in this
condition subjects must trade off the small immediate costs
incurred by information sampling against the larger
potential loss resulting from an incorrect decision.
Examining the effects of ATD on information sampling
behaviour allowed us to distinguish to what extent 5-HT
influences local aversive predictions, global aversive
predictions, and reflection impulsivity. If 5-HT promotes
avoidance of local losses, then ATD should increase
information sampling in the Costly condition but have no
effect on information sampling in the Free condition.
Conversely, if 5-HT promotes avoidance of global losses,
then ATD should increase information sampling in both the
Free and Costly conditions. If 5-HT promotes loss
avoidance at both global and local levels, then ATD should
increase information sampling in the Free condition;
whereas in the Costly condition, in which global and local
loss avoidance are hypothesised to antagonise one another,
the predicted effects of ATD are less clear. Finally, if 5-HT
normally regulates reflection impulsivity, then ATD should
increase reflection impulsivity, decreasing information
sampling in both the Free and Costly conditions. As a
further validation measure, we assessed the effects of
individual variation in self-reported depressive symptoms
(Beck Depression Inventory; Beck et al., 1996), disposi-
tional anxiety (Behavioral Inhibition Scale; Carver and
White, 1994) and impulsivity (Barratt Impulsivity Scale;
Patton and Stanford, 1995).
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Methods
Participants
The experimental protocol was approved by the Norfolk
Research Ethics Committee. Twenty-one healthy subjects
(seven males; mean age 25.6 years) were screened for
neurological and psychiatric disorders and gave written
informed consent before participating in the study. Exclu-
sion criteria included history of cardiac, hepatic, renal,
pulmonary, neurological, psychiatric or gastrointestinal
disorders, medication/drug use, and personal or family
history of major depression or bipolar affective disorder.
Participants were financially compensated for participating.
After the screening interview, participants were assigned to
receive either the tryptophan depleting drink (ATD) or the
placebo mixture on the first session in a double-blind,
approximately counterbalanced order. The Information
Sampling Task (Clark et al., 2006) was administered as
part of a larger cognitive assessment (reported separately;
Crockett et al., 2008).
General procedure
Participants completed a battery of neuropsychological tests
on two separate sessions, separated by at least 1 week.
Participants were asked to abstain from food, alcohol and
caffeine from midnight before each session. Testing
sessions commenced in the morning (between 0830 and
1030 h). Upon arrival, participants completed self-report
questionnaires, gave a blood sample, and ingested either the
placebo or the tryptophan-depleting amino acid drink. After
a resting period of approximately 5.5 h (to ensure stable
and low tryptophan levels), participants completed a second
self-report questionnaire, gave a second blood sample, and
completed the test battery.
The Positive and Negative Affect Scale (PANAS; Watson
et al., 1988) was administered on five separate occasions
throughout the session. We analysed the difference in
PANAS positive and negative affect scores from two time
points: immediately before drink ingestion and immediately
before the cognitive assessment.
Self-report measurements: depression, anxiety,
and impulsivity
At the beginning of the first session (before the ATD
procedure), we recorded self-report measures of depressive
symptoms (Beck Depression Inventory (BDI); Beck et al.,
1996), dispositional anxiety (Behavioral Inhibition Scale
(BIS); Carver and White, 1994) and non-planning impul-
sivity (Barratt Impulsivity Scale, non-planning subscale
(BARnp); Patton and Stanford, 1995). We focused on the
non-planning subscale of the Barratt because it is directly
relevant to the construct of reflection impulsivity and
displays the highest correlations with decision-making tasks
(de Wit et al., 2007; Zermatten et al., 2005).
The role of 5-HT in depression, anxiety, and impulsivity is
undoubtedly complex. Although SSRIs, which enhance 5-HT
function, are the first-line pharmacological treatment for
depression (Neumeister, 2003; Owens and Nemeroff, 1994;
Harmer, 2008), anxiety responds to SSRIs but also to
benzodiazepines, which inhibit 5-HT function (Wise et al.,
1972; Thiébot et al., 1982). Meanwhile, low 5-HT has been
associated with impulsivity in personality disorders (Deakin,
2003; Dolan et al., 2001), but treating impulsivity in
personality disorders with serotonergic drugs has had mixed
success (Rinne et al., 2002; Zanarini et al., 2004). Compar-
ing the effects of individual variation in these measures on
information sampling with those of ATD can potentially
inform an understanding of the role of 5-HT in these
disorders. Importantly, BDI and BIS scores were not
significantly correlated across subjects (r=0.278, P=0.223)
nor were BDI and BARnp scores (r=0.045, p=0.846), or
BIS and BARnp scores (r=0.341, p=0.131).
Acute tryptophan depletion procedure
Tryptophan is the amino acid precursor of serotonin (5-HT),
and dietary depletion of tryptophan causes a rapid decrease in
brain 5-HT levels (Biggio et al., 1974; Gessa et al., 1974;
Moja et al., 1989; Ardis et al., 2009; Stancampiano et al.,
1997; Carpenter et al., 1998). In the ATD procedure,
tryptophan was depleted by ingestion of a liquid amino acid
load that did not contain tryptophan but did include other
large neutral amino acids (LNAAs). Amino acid mixtures
(prepared by SHS International, Liverpool, UK) were as
follows:
ATD: L-alanine, 4.1 g; L-arginine, 3.7 g; L-cystine, 2.0 g;
glycine, 2.4 g; L-histidine, 2.4 g; L-isoleucine, 6 g; L-
leucine, 10.1 g; L-lysine, 6.7 g; L-methionine, 2.3 g; L-
proline, 9.2 g; L-phenylalanine, 4.3 g; L-serine, 5.2 g; L-
threonine, 4.9 g; L-tyrosine, 5.2 g; and L-valine, 6.7 g.
Total: 75.2 g.
Placebo: same as ATD, plus 3.0 g of L-tryptophan. Total:
78.2 g.
For females, 20% reductions in the above quantities
were used to account for lower body weight. The drinks
were prepared by stirring the mixture and lemon–lime
flavouring into 200 ml tap water.
Information Sampling Task
The task was programmed in Microsoft Visual Basic 6.0 and
administered on a touch-sensitive monitor. Test instructions
(see “Appendix 1”) were read aloud to the subject before a
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single practice trial. After practice, the subject was encour-
aged to ask any questions before starting the main task. On
each trial (Fig. 1), subjects were presented with a 5×5 matrix
of grey boxes, with two larger coloured panels at the foot of
the screen. Touching a grey box caused the box to open
(immediately) to reveal one of the two colours. The task was
to decide the box colour in the majority on the board. The
ratio of the two colours varied across trials from 8:17 to
12:13. Two pseudorandomised sequences were created as
parallel forms and subjects were randomly assigned to either
sequence on their first session. Opened boxes remained open
for the duration of the trial. Subjects were able to open the
boxes at their own rate, and the instructions emphasised that
the subject could open as many boxes as they wished before
making their decision.
Upon touching one of the coloured panels, the remaining
boxes were uncovered and a feedback message “Correct! You
have won [x] points” or “Wrong! You have lost 100 points”
was presented for 2 s. The length of the inter-trial interval
was adjusted, based on the response time for each trial, to
establish a minimum duration of 30 s per trial. This feature
was inserted to counteract delay-averse responding. During
this delay, the current points total was presented centrally.
Subjects completed 10 trials in each of two conditions, with
condition order counterbalanced across subjects. In the Free
condition (previously called the ‘Fixed Win’ in Clark et al.,
2006), the subject won or lost 100 points on each trial,
irrespective of the number of boxes opened. In the Costly
condition (previously called the ‘Decreasing Win’ condition),
the available win decreased from 250 points in 10 point steps
with every box opened (e.g., responding correctly after
opening 12 boxes would yield 130 points). In the Costly
condition, an incorrect decision lost 100 points, regardless of
the number of boxes opened. Critically, the amount to be
potentially won or lost on each trial was displayed in the
upper left corner of the screen (Fig. 1). The only difference
between the Free and Costly conditions was that the amount
listed next to “Win” stayed fixed at 100 points in the Free
condition but decreased by 10 with each box opened in the
Costly condition.
To assess our critical dependent measure, the degree of
information sampling in each condition, we calculated the
probability of the subject being correct at the point of
decision [P(correct)]. Under some circumstances, the
number of boxes opened provides a limited index of the
information available. For example, if the subject opens 20
boxes, these might be distributed 10 yellow and 10 blue [P
(yellow)=0.5] or 15 yellow and 5 blue [P(yellow)=1.0].
The P(correct) equation precisely quantifies the extent of
information revealed on a trial-by-trial basis, although this
variable is invariably correlated with the number of boxes
opened. P(correct) is calculated with the formula:







where Z=25−(number of boxes opened), and A=13−
(number of boxes of the chosen colour). For example, if a
Fig. 1 Screen display for the Information Sampling Task (Costly
condition). Each trial commenced (left) with the presentation of 25
grey boxes arranged in a 5×5 matrix, covering a random assortment of
two colours of squares; these two colours were displayed on panels at
the foot of the screen. When the subject touched a box (middle), it
opened to reveal its colour. Subjects were instructed to decide which
of the two colours was in the majority on the board. They were told
they could open as many boxes as they wished and to touch the
corresponding panel at the foot of the screen (bottom right) once they
had decided which colour was in the majority. The amount to be won
or lost on the current trial was displayed in the upper left corner; in the
Costly condition, the “Win” amount decreased by 10 with each box
opened. Reprinted from Biological Psychiatry, vol. 60, L. Clark et al.,
Reflection impulsivity in current and former substance users, p. 516,
Copyright (2006), with permission from Elsevier
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decision is made toward yellow after opening 10 boxes (8
yellow, 2 blue), then Z=25–10=15, A=13–8 =, and
P correctð Þ ¼ 15!= 5! 10!ð Þ þ 15!= 6! 9!ð Þ þ . . .þ 15!=½
b 15! 0!ð Þ=215 ¼ 0:94.
General task performance was indexed by the number of
correct judgments in each condition and total number of
points scored. We also assessed the average box opening




Blood samples (10 ml) were analysed to determine the total
plasma TRP level and the TRP:ΣLNAA ratio. This ratio was
calculated from the serum concentrations of total tryptophan
divided by the sum of the large neutral amino acids (tyrosine,
phenylalanine, valine, isoleucine, and leucine) and is impor-
tant because the uptake of TRP in the brain is strongly
associated with the amounts of other competing LNAAs due
to non-specific transport across the blood–brain barrier.
Venous samples were taken in lithium heparin tubes and
stored at −20°C. Plasma TRP concentrations were determined
by an isocratic high performance liquid chromatography
(HPLC) method of analysis. Plasma proteins were removed
by precipitation with 3% trichloroacetic acid and centrifuga-
tion at 3,000 rpm, 4°C for 10 min and then pipetted into
heparin aliquots. An aliquot was diluted in mobile phase
before injection onto the HPLC analytical column. Fluores-
cence end-point detection was used to identify TRP.
Behavioural measures
We assessed the effects of ATD on Information Sampling Task
performance using repeated-measures analysis of variance
(ANOVA; PASW 18, Chicago, IL) of condition (Free, Costly)
by treatment (ATD, placebo). The effects of individual
differences in BDI and BIS scores on task performance were
examined with simple linear regressions. Interactions between
treatment and BDI/BIS/BARnp scores were tested using
repeated-measures analysis of covariance. Condition order,
treatment order, and gender were initially included as
between-subjects factors and dropped from subsequent
analyses when non-significant.
We report two-tailed P-values. Greenhouse–Geisser
corrections were applied when the sphericity assumption
was violated. The data in the figures represent raw data.
Results
Biochemical measures
The ATD procedure resulted in significant reductions in
both plasma TRP levels and the TRP:ΣLNAA ratio. A
repeated-measures ANOVA revealed a significant two-way
interaction between treatment (ATD, placebo) and time
point (baseline, +5.5 h), resulting from significant reduc-
tions in total TRP levels (F=75.787, P<0.0001) and the
TRP:ΣLNAA ratio (F=46.358, P<0.0001), 5.5 h following
ATD relative to placebo. Simple effects analyses showed a
significant decrease in plasma TRP levels (T=4.262, P<
0.0001) on the ATD session, averaging 56%. There was
also a significant decrease in TRP:ΣLNAA ratios (T=
10.641, P<0.001) on the ATD session, averaging 77%. On
the placebo session, plasma TRP levels increased by an
average of 54% (T=−5.840, P<0.0001), but there was no
significant change in TRP:ΣLNAA ratios (T=−1.220, P=
0.232).
Self-report mood
We examined the effects of time, treatment, and their
interaction on PANAS positive and negative affect (Table 1).
For positive affect, there were no significant effects of time
(F=1.691, P=0.203), treatment (F=0.573, P=0.455), or
time×treatment interaction (F=2.009, P=0.167). For nega-
tive affect, there was a decrease over time in both sessions
(main effect of time, F=6.4, P=0.021), but there was no
significant effect of treatment (F=0.347, P=0.563) or
treatment × interaction (F=0.793, P=0.380).
Information Sampling Task performance
Information sampling
The degree of information sampling was assessed using the
dependent measure P(correct) at decision, which was
highly correlated with the number of boxes opened but
Table 1 Effects of time and
treatment on self-report mood
scores. Results are reported as




T1 T2 T1 T2
Positive affect 3.912 (0.177) 3.618 (0.167) 1.237 (0.093) 1.142 (0.061)
Negative affect 3.692 (0.196) 3.654 (0.182) 1.216 (0.06) 1.084 (0.04)
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provided a more sensitive measure of the information
available at the time of decision (see “Methods’). As
expected, information sampling was related to accuracy. P
(correct) was significantly correlated with the number of
correct judgments in both the Free condition (ATD: r=
0.737, P<0.001; PLA: r=0.590, P<0.005) and the Costly
condition (ATD: r=0.900, P<0.001, PLA: r=0.832, P<
0.001), and as these measures were correlated, we focus our
analysis on the P(correct) variable.
Repeated-measures ANOVA revealed a significant
main effect of condition on information sampling (F=
79.946, P<0.0001) such that participants sampled less
information in the Costly condition compared to the Free
condition. The main effect of treatment was not significant
(F=1.783, P=0.197), but there was a significant condi-
tion×treatment interaction (F=4.945, P=.038). The con-
dition×treatment interaction remained significant when
including treatment order in the model as a between-
subjects factor (F=5.577, P=0.029). Treatment order was
not itself significant nor did it interact significantly with
any other factor (all P>0.136). Post-hoc paired t-tests
conducted on the Free and Costly conditions separately
showed that ATD tended to increase information sampling
in the Costly condition (t=1.991, P=0.060) but not in the
Free condition (t=−0.143, P=0.888). Figure 2 shows the
average information sampled per trial as a function of
condition and treatment.
To examine the relationship between individual differ-
ences in depressive symptomology and information sam-
pling, we computed correlations between BDI scores and
information sampling (indexed by P(correct)) in the Free
and Costly conditions, both averaged across treatments and
in the placebo session only. BDI scores were positively
correlated with information sampling in the Costly condi-
tion (r=0.527, P=0.014; PLA only: r=0.510, P=0.018;
Fig. 3a). This correlation was not significant in the Free
condition (r=0.365, P=0.103; PLA only: r=0.368, P=
0.100; Fig. 3b), although the coefficients for the Free and
Costly conditions were not significantly different from one
another (Steiger's Z=0.64, P=0.52).
We conducted the same analysis on the BIS scores. Here
we found the reverse pattern: BIS scores were positively
correlated with information sampling in the Free condition
(r=0.583, P=0.006; PLA only: r=0.537, P=0.012; Fig. 4a)
but not significantly correlated with information sampling
in the Costly condition (r=0.146, P=0.527; PLA only: r=
0.091, P=0.695; Fig. 4b). These two correlations were
significantly different from one another at the trend level
(Steiger's Z=1.65, P=0.098). The observation that individ-
ual differences in the Free condition were systematically
related to trait inhibition levels may potentially mitigate
against a ceiling effect in the Free condition, although we
acknowledge that a ceiling effect in the Free condition
cannot be ruled out completely.
Meanwhile, there was no relationship between self-
reported impulsivity (BARnp) and information sampling,
in either the Free condition (r=0.328, P=0.147; PLA only:
r=0.073, P=0.755) or the Costly condition (r=−0.116, P=
0.619; PLA only: r=−0.170, P=0.461).
Despite the non-significant correlations between our
three self-report measures, as a further precaution against
the relatively small sample size, we computed a series of
partial correlations to verify that BDI and BIS scores
exerted independent effects on information sampling. BDI
scores were significantly correlated with information
sampling in the Costly condition when controlling for BIS
scores (r=0.511, P=0.021; PLA only: r=0.507, P=0.023)
and BARnp scores (r=0.536, P=0.015; PLA only: r=
0.526, P=0.017). Similarly, BIS scores were significantly
correlated with information sampling in the Free condition
when controlling for BDI scores (r=0.538, P=0.014; PLA
only: r=0.487, P=0.030) and BARnp scores (r=0.531, P=
0.016; PLA only: r=0.546, P=0.013).
Because BDI and BIS scores exerted significant effects
on information sampling, we further examined whether
these effects interacted with those of ATD. When including
Fig. 2 a The mean information sampled per trial (defined as P
(correct) at decision) as a function of condition (Free, Costly) and
treatment [placebo (PLA), ATD]. b The mean change in information
sampling from the Free condition to the Costly condition as a function
of treatment. Error bars represent the standard error of the difference
between treatments
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BDI scores as a covariate in a repeated-measures ANOVA,
we found significant effects of condition (F=79.946, P<
0.001), condition-by-treatment (F=4.945, P=0.038), and
BDI (F=9.837, P=0.005) on information sampling, but no
significant interactions between treatment and BDI (all P>
0.425). We observed similar results for BIS: including BIS
scores as a covariate, there were significant effects
of condition (F=84.525, P<0.001), condition-by-treatment
(F=4.782, P=0.041), and BIS (F=4.729, P=0.043) but no
significant interactions between treatment and BIS (all P>
0.729).
Points scored
Despite differences in strategy between conditions and
treatments, participants earned the same number of points,
on average, in both conditions and both treatments.
Repeated-measures ANOVA showed no significant effects
of condition (F=0.482, P=0.496), treatment (F=0.133, P=
0.720), or their interaction (F=0.255, P=0.620) on points
scored. None of the self-report measures (BDI, BIS, and
BARnp) significantly correlated with points scored in either
the Free or Costly conditions (all p>0.164).
Discussion
We examined the effects of ATD on free and costly
information sampling in the context of a reflection
impulsivity task. ATD appeared to selectively disinhibit
the suppressive effects of small local losses on information
sampling behaviour; it increased costly information sam-
pling whilst leaving free information sampling unaffected.
Our results are consistent with a recent theoretical model
that characterises 5-HT as pruning a tree of potential
decisions, eliminating options expected to lead to aversive
outcomes (Dayan, 2008). Here, we clarify this prediction
by proposing that 5-HT promotes reflexive avoidance of
relatively immediate aversive outcomes, potentially at the
expense of more globally construed future losses. Our
findings complement those of a recent study showing that
ATD increased the tendency to accept small losses rather
Fig. 3 Correlations between BDI scores and information sampling (P(correct) at decision) in the Costly condition (a) and Free condition (b),
averaged across treatment conditions
Fig. 4 Correlations between BIS scores and information sampling (P(correct) at decision) in the Costly condition (a) and Free condition (b),
averaged across treatment conditions
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than risk larger losses to recover them in a ‘loss-chasing’
gambling context (Campbell-Meiklejohn et al., 2011). A
focus on avoiding immediate losses could be adaptive
under stressful conditions. Indeed, acute stressors activate
the 5-HT releasing neurons of the raphé nuclei (Joëls and
Baram, 2009; Takase et al., 2004), which could promote
inhibition of locally costly actions. However, when stres-
sors are controllable (for example, by instrumental escape
actions), 5-HT release is inhibited (Amat et al., 2005); this
could ‘release’ actions that may be costly in the short-term
but lead ultimately to the avoidance of more global threats.
Previous studies using the Information Sampling Task
suggested that subjects sampled less information in the
Costly condition (relative to the Free condition) in order to
maximise rewards (Clark et al., 2006; Clark et al., 2009). In
the current study, we suggest an alternative construal: that
subjects sample less information in the Costly condition to
avoid losing potential winnings. These motivational explan-
ations need not be mutually exclusive; indeed, a recent
study reported similar activations in the striatum when
subjects emitted actions to win money, and when they
emitted actions to avoid losing money (Guitart-Masip et al.,
2011). Interpreting our results in terms of loss avoidance is
further bolstered by our analysis of the self-report data.
Sub-clinical depressive and anxious symptoms exerted
distinct and independent effects on information sampling
and did not interact with the effects of ATD. Depressive
symptoms (BDI scores) influenced behaviour in a similar
direction as ATD, with more highly depressive subjects
showing increased costly information sampling (although
we note that this correlation did not differ significantly from
the correlation between BDI scores and free information
sampling). This finding fits with the observation that
depression is believed to be associated with decreased 5-
HT levels, and ATD has been reported to induce depressive
symptoms in people with a history of depression (Delgado
et al., 1990). Reduced avoidance of potentially aversive
outcomes, putatively associated with impaired 5-HT func-
tion, could be a risk factor for clinical depression (Dayan,
2008). This idea is supported by studies showing that
depression is associated with increased cognitive engage-
ment with aversive stimuli (Joormann and Gotlib, 2006;
Harmer et al., 2009) and that treatment with SSRIs can
reduce this negative cognitive bias (Harmer et al., 2009).
Moreover, these findings are in line with observations that
depressed patients and dysphoric subjects can show a
tendency to ruminatively analyse their symptoms (Nolen-
Hoeksema, 2000)—a kind of ‘costly information sampling.’
It would be worthwhile to examine costly information
sampling behaviour in depressed patients both on and off
medication or repeatedly over the course of treatment.
Increased sensitivity to the effects of cost on information
sampling could be an early predictor of response to
treatment with antidepressants that may be detectable
sooner than changes in depressive symptoms, just as
antidepressant-induced changes in negative cognitive biases
occur earlier than changes in mood (Harmer, 2008).
Meanwhile, dispositional anxiety (BIS scores) was
positively correlated with free information sampling but
was unrelated to costly information sampling (although we
note that the difference in correlations was significant only
at the trend level). This finding suggests that anxious
individuals are sensitive to potential losses at both the local
and the global levels. When information sampling is free,
increased sensitivity to potential global losses would lead to
greater information sampling to avoid those losses; but
when information sampling is costly, avoidance of losses at
the local level could antagonise avoidance of losses at the
global level. Previous studies have associated BIS scores
with enhanced sensitivity to losses and threat (Perkins et al.,
2010; Field, 2006; Smillie et al., 2007). The current study
extends these findings to a setting involving decision-
making under conflict and suggests that the cost of
information sampling moderates the influence of anxiety
on decision-making.
These findings also add to a growing literature indicating
a complex relationship between 5-HT and impulsivity. In
the current study, we examined the effect of ATD on
‘reflection impulsivity’ or the tendency to make decisions
before gathering sufficient or appropriate information
(Kagan, 1966). Contrary to a simple account linking
reduced 5-HT function with increased impulsivity, in the
current study, there was no overall main effect of ATD on
information sampling, and ATD tended to reduce reflection
impulsivity by attenuating the impact of cost on informa-
tion sampling. In addition, there was no significant
relationship between trait impulsivity (BARnp) and infor-
mation sampling suggesting that variation in behaviour in
the current study depended primarily on differences in
aversive processing. Rather than promoting self-control in
general, 5-HT more likely regulates the effects of aversive
predictions on cognition and behaviour, which can result in
behavioural inhibition (when behaviour leads to aversive
outcomes) and also reduced cognitive reflection (when
thoughts lead to aversive feelings) (Crockett et al., 2009;
Dayan, 2008).
The present findings are also relevant for understanding the
cognitive effects of drugs of abuse that target different
neurotransmitter systems. Using the same Information Sam-
pling Task as in the current study, previous studies have
shown increased reflection impulsivity (i.e., reduced informa-
tion sampling) in current and former users of amphetamines,
opiates, and cannabis (Clark et al., 2006; Clark et al.,
2009). Intriguingly, however, current and former users of
MDMA (‘ecstasy’) did not differ from controls in
reflection impulsivity in the Information Sampling Task,
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despite showing elevated self-reported impulsivity (Clark
et al., 2009). Our results may help to explain this puzzling
finding. As MDMA has neurotoxic effects on 5-HT
neurons (Gouzoulis-Mayfrank and Daumann, 2006), cur-
rent and former MDMA users may have reduced 5-HT
neurotransmission, which could produce behavioural
effects similar to ATD. In our study, ATD tended to
reduce reflection impulsivity; thus, neurotoxic effects of
MDMA could have counteracted the effects of trait-level
impulsivity on information sampling in MDMA users.
In sum, we found that temporarily disrupting 5-HT
function in humans with an ATD manipulation attenuated
the impact of cost on information sampling behaviour.
These results suggest that 5-HT directs reflexive avoidance
of immediate aversive outcomes and imply that considering
both global and local construals of threat is a useful
construct for examining the effects of 5-HT on aversively
motivated cognition and behaviour.
Appendix 1: IST instructions
The subject was instructed, “You are about to play a game
for points. The game will take 10 minutes to complete. It
consists of two parts and on each part there will be 10
gos. On every go, you will be able to see 25 boxes on the
screen. Initially, the boxes will all be greyed out, but
when you pick a box, it will reveal itself to be one of two
colours. Your task is to decide which colour you think is
in the majority. It is entirely up to you how many boxes
you open before making your decision. When you have
made your decision, you should touch that colour panel at
the bottom of the screen.” These instructions were read to
the subject during a practice trial, during which 100 points
were available to win or lose for a correct or wrong
response. This practice trial was identical to the Fixed
Win condition, for which it was further reiterated, “You
will win 100 points if you pick the correct colour,
regardless of how many boxes you open, and you can
open as many boxes as you wish. You will lose 100 points
if you get it wrong. Try to win as many points as you
can.” In the Decreasing Win condition, subjects were
instructed, “On these gos, the amount you can win will
drop by 10 points with every box you uncover, therefore
the earlier you make your decision the more points you
will win if you are right. If you are wrong, you will lose
100 points regardless of when you make your decision.
Try to win as many points as you can.”
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